It is a pharma private limited company based in Patna, Bihar, India, established in 2015.
2015 | Patna, Bihar, India | ActiveRubisco Pharmaceuticals Private Limited, a active private limited company, was established on 29 July 2015 in Patna, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230BR2015PTC024667. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹3.25 Cr and a paid-up capital of ₹3.25 Cr.
It upholds a compliant status. Employing 13 professional, Its leadership includes Sangita Devi (Director), Pinki Ray (Director), Soniya Nigam (Director). Past directors included Ajay Kumar Jha, Abhinita. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Narendra Kumar Nigam, Near Middle School, Power House, Karbigahiya, Patna, Bihar, 800001.
U24230BR2015PTC024667
024667
29 July 2015
₹3.25 Cr
₹3.25 Cr
Roc Patna
Unlisted
Active
Explore comprehensive insights into Rubisco Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangita Devi | Director | 01 Mar 2024 | Current |
| Pinki Ray | Director | 29 Jul 2015 | Current |
| Soniya Nigam | Director | 29 Jul 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rubisco Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.33% increase. The company also saw a slight improvement in profitability, with a 5.87% increase in profit. The company's net worth Soared by an impressive increase of 26.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rubisco Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2017 | State Bank Of India | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Rubisco Pharmaceuticals has a workforce of 13 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rubisco Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rubisco Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rubisco Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Rubisco Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was completed.
The activity Sangita Devi was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
A charge with State Bank Of India amounted to Rs. 0.05 Cr with Charge ID 100133829 was registered on 30 Mar 2017. was recorded as a recent event.
The activity Pinki Ray was appointed as a Director was appointed as a Director on 29 Jul 2015 & has been associated with this company since 10 years 3 months . was completed.
The activity Soniya Nigam was appointed as a Director was appointed as a Director on 29 Jul 2015 & has been associated with this company since 10 years 3 months . was completed.
The CIN of Rubisco Pharmaceuticals Private Limited is U24230BR2015PTC024667.
Rubisco Pharmaceuticals Private Limited is headquartered at C/O Narendra Kumar Nigam, Near Middle School, Power House, Karbigahiya, Patna, Bihar, 800001.
Rubisco Pharmaceuticals Private Limited was incorporated on 29 July 2015.
The current directors of Rubisco Pharmaceuticals Private Limited are
The primary industry of Rubisco Pharmaceuticals Private Limited is Trade.
Rubisco Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rubisco Pharmaceuticals Private Limited is ₹3.25 Cr, and the paid-up capital is ₹3.25 Cr.
The compliance status of Rubisco Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX